Labeler
Hikma Pharmaceuticals USA Inc. NDC Codes
Hikma Pharmaceuticals USA Inc. lists 754 finished drug products in the FDA NDC Directory under NDC labeler codes 0054, 0143, 0641, 24201.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Tapentadol, Ropivacaine Hydrochloride, Tyzavan, Daptomycin, Lithium Carbonate, Eltrombopag, Cefepime Hydrochloride, Starjemza, Gemcitabine, Vancomycin Hydrochloride, Levetiracetam in Sodium Chloride, dicyclomine hydrochloride, Meropenem, Atropine Sulfate, Fentanyl Citrate
- Active ingredients
- Tapentadol hydrochloride, Ropivacaine hydrochloride, Vancomycin, Daptomycin, Lithium carbonate, Eltrombopag olamine, Cefepime hydrochloride, Ustekinumab, Gemcitabine hydrochloride, Vancomycin hydrochloride, Levetiracetam, Dicyclomine hydrochloride
- NDC labeler codes
- 0054, 0143, 0641, 24201
- Strengths (from the 100 most recently listed products)
- Daptomycin 500 mg/10mL; Ropivacaine hydrochloride 2 mg/mL; Gemcitabine hydrochloride 38 mg/mL; Lithium carbonate 300 mg/1; Daptomycin 350 mg/7mL; Tapentadol hydrochloride 100 mg/1; Tapentadol hydrochloride 50 mg/1; Ropivacaine hydrochloride 5 mg/mL; Cefepime hydrochloride 1 g/1; Cefepime hydrochloride 2 g/1; Ustekinumab 45 mg/.5mL; Fentanyl citrate 50 ug/mL; Glycopyrrolate .2 mg/mL; Mercaptopurine 20 mg/mL; Dicyclomine hydrochloride 10 mg/1; Dicyclomine hydrochloride 20 mg/1; Meropenem 500 mg/10mL; Lithium carbonate 600 mg/1; Lithium carbonate 150 mg/1; Sugammadex sodium 100 mg/mL
- Dosage forms
- Injection, Injection, Solution, Injection, Powder, For solution, Tablet, Injection, Powder, Lyophilized, For solution, Tablet, Film coated, Tablet, Film coated, Extended release, Capsule, Capsule, Gelatin coated, Solution, Suspension, Liquid, Injection, Suspension, Suppository
- Routes
- Intravenous, Oral, Intramuscular, Subcutaneous, Epidural, Infiltration, Perineural, Intravascular, Intrathecal, Ophthalmic, Intra-articular, Rectal
- Drug classes (FDA established)
- Opioid Agonist, Glycopeptide Antibacterial, Amide Local Anesthetic, Anticholinergic, Lipopeptide Antibacterial, Nucleoside Metabolic Inhibitor, Mood Stabilizer, Thrombopoietin Receptor Agonist, Cholinergic Muscarinic Antagonist, Cephalosporin Antibacterial, Interleukin-12 Antagonist, Interleukin-23 Antagonist, Penem Antibacterial, alpha-Adrenergic Agonist, beta-Adrenergic Agonist, Polymyxin-class Antibacterial, RANK Ligand Inhibitor, Serotonin-4 Receptor Agonist, Antiarrhythmic, Progesterone, Nondepolarizing Neuromuscular Blocker, Nonsteroidal Anti-inflammatory Drug, Benzodiazepine, Catecholamine, Janus Kinase Inhibitor, Antidote, Antidote for Acetaminophen Overdose, Mucolytic, Central alpha-2 Adrenergic Agonist, Prostaglandin Analog, Phenylalanine Hydroxylase Activator, Atypical Antipsychotic, beta-Adrenergic Blocker, Opioid Antagonist, Oxidation-Reduction Agent, Corticosteroid, GLP-1 Receptor Agonist, Norepinephrine Releasing Agent
- HCPCS / J-code
- J0171 — Injection, adrenalin, epinephrine, 0.1 mg, J0897 — Injection, denosumab, 1 mg, J3357 — Injection, ustekinumab, for subcutaneous injection, 1 mg
- Package NDCs
- 111 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| dicyclomine hydrochloride | Dicyclomine hydrochloride 10 mg/1 | CapsuleOral | 0054-0883 | 00054-0883-2500054-0883-31 | — |
| dicyclomine hydrochloride | Dicyclomine hydrochloride 20 mg/1 | TabletOral | 0054-0885 | 00054-0885-2500054-0885-31 | — |
| Meropenem | Meropenem 500 mg/10mL | Injection, Powder, For solutionIntravenous | 0143-9485 | 00143-9485-10 | — |
| Lithium Carbonate | Lithium carbonate 300 mg/1 | Capsule, Gelatin coatedOral | 0054-0890 | 00054-0890-2500054-0890-31 | — |
| Lithium Carbonate | Lithium carbonate 300 mg/1 | TabletOral | 0054-0886 | 00054-0886-2500054-0886-31 | — |
| Lithium Carbonate | Lithium carbonate 600 mg/1 | Capsule, Gelatin coatedOral | 0054-0891 | 00054-0891-25 | — |
| Lithium Carbonate | Lithium carbonate 150 mg/1 | Capsule, Gelatin coatedOral | 0054-0887 | 00054-0887-25 | — |
| Sugammadex | Sugammadex sodium 100 mg/mL | InjectionIntravenous | 0641-6270 | 00641-6270-10 | — |
| Diazepam | Diazepam 5 mg/mL | Injection, SolutionIntramuscular, Intravenous | 0641-6283 | 00641-6283-25 | — |
| Epinephrine | Epinephrine 1 mg/mL | InjectionIntramuscular, Intravenous, Subcutaneous | 0143-9476 | 00143-9476-25 | J0171 |
| Meropenem | Meropenem 1 g/20mL | Injection, Powder, For solutionIntravenous | 0143-9486 | 00143-9486-10 | — |
| tofacitinib solutiontofacitinib | Tofacitinib citrate 1 mg/mL | SolutionOral | 0054-0821 | 00054-0821-58 | — |
| Eltrombopageltrombopag olamine | Eltrombopag olamine 12.5 mg/1 | TabletOral | 0054-0962 | 00054-0962-13 | — |
| Eltrombopageltrombopag olamine | Eltrombopag olamine 75 mg/1 | TabletOral | 0054-0965 | 00054-0965-13 | — |
| Eltrombopageltrombopag olamine | Eltrombopag olamine 25 mg/1 | TabletOral | 0054-0963 | 00054-0963-13 | — |
| Eltrombopageltrombopag olamine | Eltrombopag olamine 50 mg/1 | TabletOral | 0054-0964 | 00054-0964-13 | — |
| Acetylcysteine | Acetylcysteine 200 mg/mL | Injection, SolutionIntravenous | 0143-9433 | 00143-9433-04 | — |
| Colistimethatecolistimethate sodium | Colistimethate sodium 150 mg/1 | Injection, Powder, For solutionIntramuscular, Intravenous | 0143-9443 | 00143-9443-0100143-9443-12 | — |
| Dexmedetomidine Hydrochloride | Dexmedetomidine hydrochloride 4 ug/mL | Injection, SolutionIntravenous | 0143-9198 | 00143-9198-10 | — |
| Carboprost Tromethamine | Carboprost tromethamine 250 ug/mL | SolutionIntramuscular | 0143-9442 | 00143-9442-10 | — |
| Daptomycin | Daptomycin 350 mg/7mL | Injection, Powder, Lyophilized, For solutionIntravenous | 0143-9455 | 00143-9455-01 | — |
| Enobydenosumab-qbde | Denosumab 60 mg/mL | InjectionSubcutaneous | 0143-9165 | 00143-9165-01 | J0897 |
| Xtrenbodenosumab-qbde | Denosumab 120 mg/1.7mL | InjectionSubcutaneous | 0143-9166 | 00143-9166-01 | J0897 |
| Tapentadoltapentadol hydrochloride | Tapentadol hydrochloride 100 mg/1 | Tablet, Film coated, Extended releaseOral | 0054-0937 | 00054-0937-21 | — |
| Tapentadoltapentadol hydrochloride | Tapentadol hydrochloride 75 mg/1 | Tablet, Film coatedOral | 0054-0943 | 00054-0943-25 | — |
| Tapentadoltapentadol hydrochloride | Tapentadol hydrochloride 250 mg/1 | Tablet, Film coated, Extended releaseOral | 0054-0940 | 00054-0940-21 | — |
| Tapentadoltapentadol hydrochloride | Tapentadol hydrochloride 150 mg/1 | Tablet, Film coated, Extended releaseOral | 0054-0938 | 00054-0938-21 | — |
| Tapentadoltapentadol hydrochloride | Tapentadol hydrochloride 50 mg/1 | Tablet, Film coated, Extended releaseOral | 0054-0936 | 00054-0936-21 | — |
| Tapentadoltapentadol hydrochloride | Tapentadol hydrochloride 100 mg/1 | Tablet, Film coatedOral | 0054-0945 | 00054-0945-25 | — |
| Tapentadoltapentadol hydrochloride | Tapentadol hydrochloride 50 mg/1 | Tablet, Film coatedOral | 0054-0942 | 00054-0942-25 | — |
| Tapentadoltapentadol hydrochloride | Tapentadol hydrochloride 200 mg/1 | Tablet, Film coated, Extended releaseOral | 0054-0939 | 00054-0939-21 | — |
| Daptomycin | Daptomycin 500 mg/10mL | Injection, Powder, Lyophilized, For solutionIntravenous | 0143-9445 | 00143-9445-01 | — |
| Daptomycin | Daptomycin 350 mg/7mL | Injection, Powder, Lyophilized, For solutionIntravenous | 0143-9456 | 00143-9456-01 | — |
| Ropivacaine Hydrochloride | Ropivacaine hydrochloride 2 mg/mL | InjectionEpidural, Infiltration | 0143-9263 | 00143-9263-10 | — |
| Ropivacaine Hydrochloride | Ropivacaine hydrochloride 5 mg/mL | InjectionEpidural, Infiltration | 0143-9264 | 00143-9264-10 | — |
| Ropivacaine Hydrochloride | Ropivacaine hydrochloride 7.5 mg/mL | InjectionEpidural | 0143-9265 | 00143-9265-10 | — |
| Ropivacaine Hydrochloride | Ropivacaine hydrochloride 10 mg/mL | InjectionEpidural | 0143-9266 | 00143-9266-10 | — |
| Ropivacaine Hydrochloride | Ropivacaine hydrochloride 2 mg/mL | Injection, SolutionEpidural, Infiltration, Perineural | 0143-9195 | 00143-9195-24 | — |
| Ropivacaine Hydrochloride | Ropivacaine hydrochloride 2 mg/mL | Injection, SolutionEpidural, Infiltration, Perineural | 0143-9196 | 00143-9196-12 | — |
| Ropivacaine Hydrochloride | Ropivacaine hydrochloride 5 mg/mL | Injection, SolutionEpidural, Infiltration, Perineural | 0143-9197 | 00143-9197-24 | — |
| Atropine Sulfate | Atropine sulfate .4 mg/mL | InjectionIntravascular | 0641-6274 | 00641-6274-25 | — |
| Atropine Sulfate | Atropine sulfate 1 mg/mL | InjectionIntravenous | 0641-6275 | 00641-6275-25 | — |
| Cefepime Hydrochloride | Cefepime hydrochloride 1 g/1 | Injection, Powder, For solutionIntramuscular, Intravenous | 0143-9477 | 00143-9477-10 | — |
| Cefepime Hydrochloride | Cefepime hydrochloride 2 g/1 | Injection, Powder, For solutionIntravenous | 0143-9478 | 00143-9478-10 | — |
| Starjemzaustekinumab-hmny | Ustekinumab 45 mg/.5mL | InjectionSubcutaneous | 0143-9168 | 00143-9168-01 | J3357 |
| Starjemzaustekinumab-hmny | Ustekinumab 45 mg/.5mL | InjectionSubcutaneous | 0143-9169 | 00143-9169-01 | J3357 |
| Starjemzaustekinumab-hmny | Ustekinumab 90 mg/mL | InjectionSubcutaneous | 0143-9170 | 00143-9170-01 | J3357 |
| Starjemzaustekinumab-hmny | Ustekinumab 130 mg/26mL | InjectionIntravenous | 0143-9171 | 00143-9171-01 | — |
| sapropterin dihydrochloride | Sapropterin dihydrochloride 100 mg/1 | TabletOral | 0054-0906 | 00054-0906-23 | — |
| Gemcitabine | Gemcitabine hydrochloride 38 mg/mL | Injection, SolutionIntravenous | 0143-9342 | 00143-9342-01 | — |
Hikma Pharmaceuticals USA Inc.: common questions
- What is Hikma Pharmaceuticals USA Inc.'s NDC labeler code?
- 0054, 0143, 0641, 24201. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Hikma Pharmaceuticals USA Inc.?
- Med-Code's HCPCS directory matches J0171, J0897, J3357 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.